Update S3-Leitlinie Intestinale Motilitätsstörungen: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM)

 

 Permissions and Reprints

Publication History

Received: 09 July 2021

Accepted: 14 September 2021

Article published online:
11 February 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• Literatur

• 1 Bundesärztekammer (BÄK) KBK, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Neuropathie bei Diabetes im Erwachsenenalter – Langfassung. 2011 http://www.diabetes.versorgungsleitlinien.de
  PubMedGoogle Scholar
• 2 Layer P, Andresen V, Pehl C. et al. S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM). Z Gastroenterol 2011; 49: 237-293
  Article in Thieme ConnectPubMedGoogle Scholar
• 3 Phillips BDM, Ball C, Sackett D. et al. Oxford Centre for Evidence-based Medicine – Levels of Evidence CEBM. 2009 2009.
  PubMedGoogle Scholar
• 4 Connor FL, Di Lorenzo C. Chronic intestinal pseudo-obstruction: assessment and management. Gastroenterology 2006; 130: S29-S36
  CrossrefPubMedGoogle Scholar
• 5 Stanghellini V, Cogliandro RF, de Giorgio R. et al. Chronic intestinal pseudo-obstruction: manifestations, natural history and management. Neurogastroenterol Motil 2007; 19: 440-452
  CrossrefPubMedGoogle Scholar
• 6 Seidl H, Pehl C, Schepp W. et al. [Chronic intestinal pseudo-obstruction – review and update 2008]. Z Gastroenterol 2008; 46: 704-711
  Article in Thieme ConnectPubMedGoogle Scholar
• 7 Kessmann J. Hirschsprungʼs disease: diagnosis and management. Am Fam Physician 2006; 74: 1319-1322
  PubMedGoogle Scholar
• 8 Knowles CH, Lindberg G, Panza E. et al. New perspectives in the diagnosis and management of enteric neuropathies. Nat Rev Gastroenterol Hepatol 2013; 10: 206-218
  CrossrefPubMedGoogle Scholar
• 9 Goldstein AM, Thapar N, Karunaratne TB. et al. Clinical aspects of neurointestinal disease: Pathophysiology, diagnosis, and treatment. Dev Biol 2016; 417: 217-228
  CrossrefPubMedGoogle Scholar
• 10 Furness JB. The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol 2012; 9: 286-294
  CrossrefPubMedGoogle Scholar
• 11 Knowles CH, De Giorgio R, Kapur RP. et al. The London Classification of gastrointestinal neuromuscular pathology: report on behalf of the Gastro 2009 International Working Group. Gut 2010; 59: 882-887
  CrossrefPubMedGoogle Scholar
• 12 Boeckxstaens G, Camilleri M, Sifrim D. et al. Fundamentals of Neurogastroenterology: Physiology/Motility – Sensation. Gastroenterology 2016; 150: 1292-1304
  CrossrefPubMedGoogle Scholar
• 13 Vanner S, Greenwood-Van Meerveld B, Mawe G. et al. Fundamentals of Neurogastroenterology: Basic Science. Gastroenterology 2016; 150: 1280-1291
  CrossrefPubMedGoogle Scholar
• 14 De Giorgio R, Camilleri M. Human enteric neuropathies: morphology and molecular pathology. Neurogastroenterol Motil 2004; 16: 515-531
  CrossrefPubMedGoogle Scholar
• 15 Di Lorenzo C. Pseudo-obstruction: current approaches. Gastroenterology 1999; 116: 980-987
  CrossrefPubMedGoogle Scholar
• 16 De Giorgio R, Guerrini S, Barbara G. et al. New insights into human enteric neuropathies. Neurogastroenterol Motil 2004; 16 (Suppl. 01) 143-147
  CrossrefPubMedGoogle Scholar
• 17 Brosens E, Burns AJ, Brooks AS. et al. Genetics of enteric neuropathies. Dev Biol 2016; 417: 198-208
  CrossrefPubMedGoogle Scholar
• 18 Panza E, Knowles CH, Graziano C. et al. Genetics of human enteric neuropathies. Prog Neurobiol 2012; 96: 176-189
  CrossrefPubMedGoogle Scholar
• 19 De Giorgio R, Guerrini S, Barbara G. et al. Inflammatory neuropathies of the enteric nervous system. Gastroenterology 2004; 126: 1872-1883
  CrossrefPubMedGoogle Scholar
• 20 Smith VV, Gregson N, Foggensteiner L. et al. Acquired intestinal aganglionosis and circulating autoantibodies without neoplasia or other neural involvement. Gastroenterology 1997; 112: 1366-1371
  CrossrefPubMedGoogle Scholar
• 21 Di Nardo G, Blandizzi C, Volta U. et al. Review article: molecular, pathological and therapeutic features of human enteric neuropathies. Aliment Pharmacol Ther 2008; 28: 25-42
  CrossrefPubMedGoogle Scholar
• 22 Knowles CH, De Giorgio R, Kapur RP. et al. Gastrointestinal neuromuscular pathology: guidelines for histological techniques and reporting on behalf of the Gastro 2009 International Working Group. Acta Neuropathol 2009; 118: 271-301
  CrossrefPubMedGoogle Scholar
• 23 Koh S, Bradley RF, French SW. et al. Congenital visceral myopathy with a predominantly hypertrophic pattern treated by multivisceral transplantation. Hum Pathol 2008; 39: 970-974
  CrossrefPubMedGoogle Scholar
• 24 Dewit S, de Hertogh G, Geboes K. et al. Chronic intestinal pseudo-obstruction caused by an intestinal inflammatory myopathy: case report and review of the literature. Neurogastroenterol Motil 2008; 20: 343-348
  CrossrefPubMedGoogle Scholar
• 25 Finsterer J. Overview on visceral manifestations of mitochondrial disorders. Neth J Med 2006; 64: 61-71
  PubMedGoogle Scholar
• 26 Bassotti G, Villanacci V, Fisogni S. et al. Enteric glial cells and their role in gastrointestinal motor abnormalities: introducing the neuro-gliopathies. World J Gastroenterol 2007; 13: 4035-4041
  CrossrefPubMedGoogle Scholar
• 27 Grubisic V, Verkhratsky A, Zorec R. et al. Enteric glia regulate gut motility in health and disease. Brain Res Bull 2018; 136: 109-117
  CrossrefPubMedGoogle Scholar
• 28 Sharkey KA. Emerging roles for enteric glia in gastrointestinal disorders. J Clin Invest 2015; 125: 918-925
  CrossrefPubMedGoogle Scholar
• 29 Bassotti G, Villanacci V, Maurer CA. et al. The role of glial cells and apoptosis of enteric neurones in the neuropathology of intractable slow transit constipation. Gut 2006; 55: 41-46
  CrossrefPubMedGoogle Scholar
• 30 Bassotti G, Villanacci V, Cathomas G. et al. Enteric neuropathology of the terminal ileum in patients with intractable slow-transit constipation. Hum Pathol 2006; 37: 1252-1258
  CrossrefPubMedGoogle Scholar
• 31 Bassotti G, Villanacci V, Nascimbeni R. et al. Colonic neuropathological aspects in patients with intractable constipation due to obstructed defecation. Mod Pathol 2007; 20: 367-374
  CrossrefPubMedGoogle Scholar
• 32 Dinning PG, Bampton PA, Andre J. et al. Abnormal predefecatory colonic motor patterns define constipation in obstructed defecation. Gastroenterology 2004; 127: 49-56
  CrossrefPubMedGoogle Scholar
• 33 Iantorno G, Bassotti G, Kogan Z. et al. The enteric nervous system in chagasic and idiopathic megacolon. Am J Surg Pathol 2007; 31: 460-468
  CrossrefPubMedGoogle Scholar
• 34 Sanders KM, Ward SM, Koh SD. Interstitial cells: regulators of smooth muscle function. Physiol Rev 2014; 94: 859-907
  CrossrefPubMedGoogle Scholar
• 35 Sanders KM, Kito Y, Hwang SJ. et al. Regulation of Gastrointestinal Smooth Muscle Function by Interstitial Cells. Physiology (Bethesda) 2016; 31: 316-326
  CrossrefPubMedGoogle Scholar
• 36 Sarna SK. Are interstitial cells of Cajal plurifunction cells in the gut?. Am J Physiol Gastrointest Liver Physiol 2008; 294: G372-G390
  CrossrefPubMedGoogle Scholar
• 37 Yanagida H, Yanase H, Sanders KM. et al. Intestinal surgical resection disrupts electrical rhythmicity, neural responses, and interstitial cell networks. Gastroenterology 2004; 127: 1748-1759
  CrossrefPubMedGoogle Scholar
• 38 De Giorgio R, Sarnelli G, Corinaldesi R. et al. Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction. Gut 2004; 53: 1549-1552
  CrossrefPubMedGoogle Scholar
• 39 Iida H, Ohkubo H, Inamori M. et al. Epidemiology and clinical experience of chronic intestinal pseudo-obstruction in Japan: a nationwide epidemiologic survey. J Epidemiol 2013; 23: 288-294
  CrossrefPubMedGoogle Scholar
• 40 Smout AJ. Recent developments in gastrointestinal motility. Scand J Gastroenterol Suppl 2006: 25–31
  PubMedGoogle Scholar
• 41 Lindberg G, Tornblom H, Iwarzon M. et al. Full-thickness biopsy findings in chronic intestinal pseudo-obstruction and enteric dysmotility. Gut 2009; 58: 1084-1090
  CrossrefPubMedGoogle Scholar
• 42 Malagelada C, Karunaratne TB, Accarino A. et al. Comparison between small bowel manometric patterns and full-thickness biopsy histopathology in severe intestinal dysmotility. Neurogastroenterol Motil 2018; 30 DOI: 10.1111/nmo.13219.
  CrossrefPubMedGoogle Scholar
• 43 Stanghellini V, Cogliandro RF, De Giorgio R. et al. Natural history of chronic idiopathic intestinal pseudo-obstruction in adults: a single center study. Clin Gastroenterol Hepatol 2005; 3: 449-458
  CrossrefPubMedGoogle Scholar
• 44 Wells CI, OʼGrady G, Bissett IP. Acute colonic pseudo-obstruction: A systematic review of aetiology and mechanisms. World J Gastroenterol 2017; 23: 5634-5644
  CrossrefPubMedGoogle Scholar
• 45 Ross SW, Oommen B, Wormer BA. et al. Acute Colonic Pseudo-obstruction: Defining the Epidemiology, Treatment, and Adverse Outcomes of Ogilvieʼs Syndrome. Am Surg 2016; 82: 102-111
  CrossrefPubMedGoogle Scholar
• 46 Bernardi MP, Warrier S, Lynch AC. et al. Acute and chronic pseudo-obstruction: a current update. ANZ J Surg 2015; 85: 709-714
  CrossrefPubMedGoogle Scholar
• 47 Saunders MD. Acute colonic pseudo-obstruction. Best Pract Res Clin Gastroenterol 2007; 21: 671-687
  CrossrefPubMedGoogle Scholar
• 48 Vanek VW, Al-Salti M. Acute pseudo-obstruction of the colon (Ogilvie’s syndrome). An analysis of 400 cases. Dis Colon Rectum 1986; 29: 203-210
  CrossrefPubMedGoogle Scholar
• 49 Gladman MA, Knowles CH. Novel concepts in the diagnosis, pathophysiology and management of idiopathic megabowel. Colorectal Dis 2008; 10: 531-538 ; discussion 538–540
  CrossrefPubMedGoogle Scholar
• 50 Bharucha AE. Constipation. Best Pract Res Clin Gastroenterol 2007; 21: 709-731
  CrossrefPubMedGoogle Scholar
• 51 Martucciello G. Hirschsprungʼs disease, one of the most difficult diagnoses in pediatric surgery: a review of the problems from clinical practice to the bench. Eur J Pediatr Surg 2008; 18: 140-149
  Article in Thieme ConnectPubMedGoogle Scholar
• 52 Heanue TA, Pachnis V. Enteric nervous system development and Hirschsprung’s disease: advances in genetic and stem cell studies. Nat Rev Neurosci 2007; 8: 466-479
  PubMedGoogle Scholar
• 53 Henderson D, Zimmer J, Nakamura H. et al. Hirschsprungʼs disease in twins: a systematic review and meta-analysis. Pediatr Surg Int 2017; 33: 855-859
  CrossrefPubMedGoogle Scholar
• 54 Andresen VEP, Frieling T, Herold A. et al. S2k-Leitlinie Chronische Obstipation: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) und der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) AWMF-Registriernummer: 021/019. Z Gastroenterol 2013; 51: 21
  PubMedGoogle Scholar
• 55 Rao SS, Rattanakovit K, Patcharatrakul T. Diagnosis and management of chronic constipation in adults. Nat Rev Gastroenterol Hepatol 2016; 13: 295-305
  CrossrefPubMedGoogle Scholar
• 56 Camilleri M, Ford AC, Mawe GM. et al. Chronic constipation. Nat Rev Dis Primers 2017; 3: 17095
  CrossrefPubMedGoogle Scholar
• 57 Ouyang A, Locke 3^rd GR. Overview of neurogastroenterology-gastrointestinal motility and functional GI disorders: classification, prevalence, and epidemiology. Gastroenterol Clin North Am 2007; 36: 485-498, vii
  CrossrefPubMedGoogle Scholar
• 58 Longstreth GF, Thompson WG, Chey WD. et al. Functional bowel disorders. Gastroenterology 2006; 130: 1480-1491
  CrossrefPubMedGoogle Scholar
• 59 Wong SW, Lubowski DZ. Slow-transit constipation: evaluation and treatment. ANZ J Surg 2007; 77: 320-328
  CrossrefPubMedGoogle Scholar
• 60 Knowles CH, Farrugia G. Gastrointestinal neuromuscular pathology in chronic constipation. Best Pract Res Clin Gastroenterol 2011; 25: 43-57
  CrossrefPubMedGoogle Scholar
• 61 Bassotti G, Villanacci V. Slow transit constipation: a functional disorder becomes an enteric neuropathy. World J Gastroenterol 2006; 12: 4609-4613
  CrossrefPubMedGoogle Scholar
• 62 Rao SS. Constipation: evaluation and treatment of colonic and anorectal motility disorders. Gastroenterol Clin North Am 2007; 36: 687-711, x
  CrossrefPubMedGoogle Scholar
• 63 Bassotti G, Stanghellini V, Chiarioni G. et al. Upper gastrointestinal motor activity in patients with slow-transit constipation. Further evidence for an enteric neuropathy. Dig Dis Sci 1996; 41: 1999-2005
  CrossrefPubMedGoogle Scholar
• 64 Seidl H, Gundling F, Pehl C. et al. Small bowel motility in functional chronic constipation. Neurogastroenterol Motil 2009; 21: 1278-e122
  CrossrefPubMedGoogle Scholar
• 65 Glia A, Akerlund JE, Lindberg G. Outcome of colectomy for slow-transit constipation in relation to presence of small-bowel dysmotility. Dis Colon Rectum 2004; 47: 96-102
  CrossrefPubMedGoogle Scholar
• 66 Andromanakos N, Skandalakis P, Troupis T. et al. Constipation of anorectal outlet obstruction: pathophysiology, evaluation and management. J Gastroenterol Hepatol 2006; 21: 638-646
  CrossrefPubMedGoogle Scholar
• 67 Spiller R. Role of motility in chronic diarrhoea. Neurogastroenterol Motil 2006; 18: 1045-1055
  CrossrefPubMedGoogle Scholar
• 68 Perez de Arce E, Landskron G, Hirsch S. et al. Chronic Intestinal Pseudo-obstruction: Clinical and Manometric Characteristics in the Chilean Population. J Neurogastroenterol Motil 2017; 23: 273-280
  CrossrefPubMedGoogle Scholar
• 69 Camilleri M, Bharucha AE, di Lorenzo C. et al. American Neurogastroenterology and Motility Society consensus statement on intraluminal measurement of gastrointestinal and colonic motility in clinical practice. Neurogastroenterol Motil 2008; 20: 1269-1282
  CrossrefPubMedGoogle Scholar
• 70 Keller J, Bassotti G, Clarke J. et al. Expert consensus document: Advances in the diagnosis and classification of gastric and intestinal motility disorders. Nat Rev Gastroenterol Hepatol 2018; 15: 291-308
  CrossrefPubMedGoogle Scholar
• 71 Keller J, Franke A, Storr M. et al. Klinisch relevante Atemtests in der gastroenterologischen Diagnostik – Empfehlungen der Deutschen Gesellschaft fÅr Neurogastroenterologie und MotilitÑt sowie der Deutschen Gesellschaft fÅr Verdauungs- und Stoffwechselerkrankungen. Z Gastroenterol 2005; 43: 1071-1090
  Article in Thieme ConnectPubMedGoogle Scholar
• 72 Amiot A, Joly F, Cazals-Hatem D. et al. Prognostic yield of esophageal manometry in chronic intestinal pseudo-obstruction: a retrospective cohort of 116 adult patients. Neurogastroenterol Motil 2012; 24: 1008-e542
  CrossrefPubMedGoogle Scholar
• 73 Rao SS, Camilleri M, Hasler WL. et al. Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies. Neurogastroenterol Motil 2011; 23: 8-23
  CrossrefPubMedGoogle Scholar
• 74 Bertram F, Andresen V, Layer P. et al. Simultaneous non-invasive measurement of liquid gastric emptying and small bowel transit by combined 13C-acetate and H2-lactulose breath test. J Breath Res 2014; 8: 046007
  CrossrefPubMedGoogle Scholar
• 75 Antonucci A, Fronzoni L, Cogliandro L. et al. Chronic intestinal pseudo-obstruction. World J Gastroenterol 2008; 14: 2953-2961
  CrossrefPubMedGoogle Scholar
• 76 Pehl C, Enck P, Franke A. et al. Empfehlungen zur anorektalen Manometrie im Erwachsenenalter. Z Gastroenterol 2007; 45: 397-417
  Article in Thieme ConnectPubMedGoogle Scholar
• 77 De Giorgio R, Knowles CH. Acute colonic pseudo-obstruction. Br J Surg 2009; 96: 229-239
  CrossrefPubMedGoogle Scholar
• 78 Eisen GM, Baron TH, Dominitz JA. et al. Acute colonic pseudo-obstruction. Gastrointest Endosc 2002; 56: 789-792
  CrossrefPubMedGoogle Scholar
• 79 Saunders MD, Kimmey MB. Systematic review: acute colonic pseudo-obstruction. Aliment Pharmacol Ther 2005; 22: 917-925
  CrossrefPubMedGoogle Scholar
• 80 OʼDwyer RH, Acosta A, Camilleri M. et al. Clinical Features and Colonic Motor Disturbances in Chronic Megacolon in Adults. Dig Dis Sci 2015; 60: 2398-2407
  CrossrefPubMedGoogle Scholar
• 81 Camilleri M. New imaging in neurogastroenterology: an overview. Neurogastroenterol Motil 2006; 18: 805-812
  CrossrefPubMedGoogle Scholar
• 82 Ohkubo H, Masaki T, Matsuhashi N. et al. Histopathologic findings in patients with idiopathic megacolon: a comparison between dilated and non-dilated loops. Neurogastroenterol Motil 2014; 26: 571-580
  CrossrefPubMedGoogle Scholar
• 83 de Lorijn F, Kremer LC, Reitsma JB. et al. Diagnostic tests in Hirschsprung disease: a systematic review. J Pediatr Gastroenterol Nutr 2006; 42: 496-505
  CrossrefPubMedGoogle Scholar
• 84 Friedmacher F, Puri P. Rectal suction biopsy for the diagnosis of Hirschsprungʼs disease: a systematic review of diagnostic accuracy and complications. Pediatr Surg Int 2015; 31: 821-830
  CrossrefPubMedGoogle Scholar
• 85 Chen JZ, Jamieson DH, Skarsgard ED. Does pre-biopsy contrast enema delay the diagnosis of long segment Hirschsprung’s disease?. Eur J Pediatr Surg 2010; 20: 375-378
  Article in Thieme ConnectPubMedGoogle Scholar
• 86 Frongia G, Gunther P, Schenk JP. et al. Contrast Enema for Hirschsprung Disease Investigation: Diagnostic Accuracy and Validity for Subsequent Diagnostic and Surgical Planning. Eur J Pediatr Surg 2016; 26: 207-214
  PubMedGoogle Scholar
• 87 Rao SS, Ozturk R, Laine L. Clinical utility of diagnostic tests for constipation in adults: a systematic review. Am J Gastroenterol 2005; 100: 1605-1615
  CrossrefPubMedGoogle Scholar
• 88 An evidence-based approach to the management of chronic constipation in North America. Am J Gastroenterol 2005; 100 (Suppl. 01) S1-S4
  PubMedGoogle Scholar
• 89 Keller J, Layer P. Intestinal and anorectal motility and functional disorders. Best Pract Res Clin Gastroenterol 2009; 23: 407-423
  CrossrefPubMedGoogle Scholar
• 90 Mion F, Garros A, Brochard C. et al. 3D High-definition anorectal manometry: Values obtained in asymptomatic volunteers, fecal incontinence and chronic constipation. Results of a prospective multicenter study (NOMAD). Neurogastroenterol Motil 2017; 29 DOI: 10.1111/nmo.13049.
  CrossrefPubMedGoogle Scholar
• 91 Grossi U, Carrington EV, Bharucha AE. et al. Diagnostic accuracy study of anorectal manometry for diagnosis of dyssynergic defecation. Gut 2016; 65: 447-455
  CrossrefPubMedGoogle Scholar
• 92 Asrani VM, Yoon HD, Megill RD. et al. Interventions That Affect Gastrointestinal Motility in Hospitalized Adult Patients: A Systematic Review and Meta-Analysis of Double-Blind Placebo-Controlled Randomized Trials. Medicine (Baltimore) 2016; 95: e2463
  CrossrefPubMedGoogle Scholar
• 93 Turgeon DK. Domperidone in chronic intestinal pseudoobstruction. Gastroenterology 1990; 99: 1194
  CrossrefPubMedGoogle Scholar
• 94 Dalgic B, Sari S, Dogan I. et al. Chronic intestinal pseudoobstruction: report of four pediatric patients. Turk J Gastroenterol 2005; 16: 93-97
  PubMedGoogle Scholar
• 95 Emmanuel AV, Shand AG, Kamm MA. Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. Aliment Pharmacol Ther 2004; 19: 687-694
  CrossrefPubMedGoogle Scholar
• 96 Verne GN, Eaker EY, Hardy E. et al. Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction. Dig Dis Sci 1995; 40: 1892-901
  CrossrefPubMedGoogle Scholar
• 97 Emmanuel AV, Kamm MA, Roy AJ. et al. Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction--a double-blind, placebo-controlled, cross-over, multiple n = 1 study. Aliment Pharmacol Ther 2012; 35: 48-55
  CrossrefPubMedGoogle Scholar
• 98 Manini ML, Camilleri M, Grothe R. et al. Application of Pyridostigmine in Pediatric Gastrointestinal Motility Disorders: A Case Series. Paediatr Drugs 2018; 20: 173-180
  CrossrefPubMedGoogle Scholar
• 99 OʼDea CJ, Brookes JH, Wattchow DA. The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine. Colorectal Dis 2010; 12: 540-548
  CrossrefPubMedGoogle Scholar
• 100 Ambartsumyan L, Flores A, Nurko S. et al. Utility of Octreotide in Advancing Enteral Feeds in Children with Chronic Intestinal Pseudo-Obstruction. Paediatr Drugs 2016; 18: 387-392
  CrossrefPubMedGoogle Scholar
• 101 Xu N, Zhao J, Liu J. et al. Clinical analysis of 61 systemic lupus erythematosus patients with intestinal pseudo-obstruction and/or ureterohydronephrosis: a retrospective observational study. Medicine (Baltimore) 2015; 94: e419
  CrossrefPubMedGoogle Scholar
• 102 Raja J, Nihtyanova SI, Murray CD. et al. Sustained benefit from intravenous immunoglobulin therapy for gastrointestinal involvement in systemic sclerosis. Rheumatology (Oxford) 2016; 55: 115-119
  CrossrefPubMedGoogle Scholar
• 103 Flanagan EP, Saito YA, Lennon VA. et al. Immunotherapy trial as diagnostic test in evaluating patients with presumed autoimmune gastrointestinal dysmotility. Neurogastroenterol Motil 2014; 26: 1285-1297
  CrossrefPubMedGoogle Scholar
• 104 Nee J, Zakari M, Sugarman MA. et al. Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 2018; 16: 1569-1584.e2
  CrossrefPubMedGoogle Scholar
• 105 Kaufman PN, Krevsky B, Malmud LS. et al. Role of opiate receptors in the regulation of colonic transit. Gastroenterology 1988; 94: 1351-1356
  CrossrefPubMedGoogle Scholar
• 106 Di Stefano M, Malservisi S, Veneto G. et al. Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther JID – 8707234 2000; 14: 551-556
  CrossrefPubMedGoogle Scholar
• 107 Lauritano EC, Gabrielli M, Scarpellini E. et al. Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole. Eur Rev Med Pharmacol Sci 2009; 13: 111-116
  PubMedGoogle Scholar
• 108 Pironi L, Arends J, Bozzetti F. et al. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr 2016; 35: 247-307
  CrossrefPubMedGoogle Scholar
• 109 Olausson EA, Storsrud S, Grundin H. et al. A small particle size diet reduces upper gastrointestinal symptoms in patients with diabetic gastroparesis: a randomized controlled trial. Am J Gastroenterol 2014; 109: 375-385
  CrossrefPubMedGoogle Scholar
• 110 Camilleri M, Kerstens R, Rykx A. et al. A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med 2008; 358: 2344-2354
  CrossrefPubMedGoogle Scholar
• 111 Tack J, van Outryve M, Beyens G. et al. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives. Gut 2009; 58: 357-365
  CrossrefPubMedGoogle Scholar
• 112 Yiannakou Y, Bouchoucha M, Schiefke I. et al. Efficacy and safety of prucalopride in men with chronic constipation: a phase 3, randomized, double-blind, placebo-controlled trial. Gastroenterology 2014; 146: 1
  CrossrefPubMedGoogle Scholar
• 113 Ponec RJ, Saunders MD, Kimmey MB. Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med 1999; 341: 137-141
  CrossrefPubMedGoogle Scholar
• 114 Schang JC, Devroede G. Beneficial effects of naloxone in a patient with intestinal pseudoobstruction. Am J Gastroenterol 1985; 80: 407-411
  PubMedGoogle Scholar
• 115 Wang JL, Liu G, Liu T. et al. Intestinal pseudo-obstruction in systemic lupus erythematosus: a case report and review of the literature. Medicine (Baltimore) 2014; 93: e248
  CrossrefPubMedGoogle Scholar
• 116 Husebye E. The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy 2005; 51 (Suppl. 01) 1-22
  CrossrefPubMedGoogle Scholar
• 117 Lloyd DA, Gabe SM. Managing liver dysfunction in parenteral nutrition. Proc Nutr Soc 2007; 66: 530-538
  CrossrefPubMedGoogle Scholar
• 118 Sabate JM, Jouet P, Harnois F. et al. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg 2008; 18: 371-377
  CrossrefPubMedGoogle Scholar
• 119 Grunkemeier DM, Cassara JE, Dalton CB. et al The narcotic bowel syndrome: clinical features, pathophysiology, and management. Clin Gastroenterol Hepatol 2007; 5: 1126-1139 ; quiz 1121–1122
  CrossrefPubMedGoogle Scholar
• 120 Tuteja AK, Biskupiak J, Stoddard GJ. et al. Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain. Neurogastroenterol Motil 2010; 22: 424-430, e96
  CrossrefPubMedGoogle Scholar
• 121 Jeong ID, Camilleri M, Shin A. et al. A randomised, placebo-controlled trial comparing the effects of tapentadol and oxycodone on gastrointestinal and colonic transit in healthy humans. Aliment Pharmacol Ther 2012; 35: 1088-1096
  PubMedGoogle Scholar
• 122 Gaskell H, Derry S, Stannard C. et al. Oxycodone for neuropathic pain in adults. Cochrane Database Syst Rev 2016; 7: Cd010692
  PubMedGoogle Scholar
• 123 Szigethy E, Knisely M, Drossman D. Opioid misuse in gastroenterology and non-opioid management of abdominal pain. Nat Rev Gastroenterol Hepatol 2018; 15: 168-180
  CrossrefPubMedGoogle Scholar
• 124 Ohkubo H, Fuyuki A, Arimoto J. et al. Efficacy of percutaneous endoscopic gastro-jejunostomy (PEG-J) decompression therapy for patients with chronic intestinal pseudo-obstruction (CIPO). Neurogastroenterol Motil 2017; 29 DOI: 10.1111/nmo.13127.
  CrossrefPubMedGoogle Scholar
• 125 Tun G, Bullas D, Bannaga A. et al. Percutaneous endoscopic colostomy: a useful technique when surgery is not an option. Ann Gastroenterol 2016; 29: 477-480
  PubMedGoogle Scholar
• 126 Sabbagh C, Amiot A, Maggiori L. et al. Non-transplantation surgical approach for chronic intestinal pseudo-obstruction: analysis of 63 adult consecutive cases. Neurogastroenterol Motil 2013; 25: e680-e686
  CrossrefPubMedGoogle Scholar
• 127 Mehendale SR, Yuan CS. Opioid-induced gastrointestinal dysfunction. Dig Dis 2006; 24: 105-112
  CrossrefPubMedGoogle Scholar
• 128 Panchal SJ, Muller-Schwefe P, Wurzelmann JI. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. Int J Clin Pract 2007; 61: 1181-1187
  CrossrefPubMedGoogle Scholar
• 129 Lauro A, Zanfi C, Pellegrini S. et al. Isolated intestinal transplant for chronic intestinal pseudo-obstruction in adults: long-term outcome. Transplant Proc 2013; 45: 3351-3355
  CrossrefPubMedGoogle Scholar
• 130 Gu L, Ding C, Tian H. et al. Serial Frozen Fecal Microbiota Transplantation in the Treatment of Chronic Intestinal Pseudo-obstruction: A Preliminary Study. J Neurogastroenterol Motil 2017; 23: 289-297
  CrossrefPubMedGoogle Scholar
• 131 Hashizume N, Yagi M, Ushijima K. et al. Pharmacotherapy for pediatric chronic intestinal pseudo-obstruction: Nationwide survey in Japan. Pediatr Int 2017; 59: 467-472
  CrossrefPubMedGoogle Scholar
• 132 Loftus CG, Harewood GC, Baron TH. Assessment of predictors of response to neostigmine for acute colonic pseudo-obstruction. Am J Gastroenterol 2002; 97: 3118-3122
  CrossrefPubMedGoogle Scholar
• 133 Zhao C, Xie T, Li J. et al. Acute Colonic Pseudo-Obstruction with Feeding Intolerance in Critically Ill Patients: A Study according to Gut Wall Analysis. Gastroenterol Res Pract 2017; 2017: 9574592
  CrossrefPubMedGoogle Scholar
• 134 van der Spoel JI, Oudemans-van Straaten HM, Stoutenbeek CP. et al. Neostigmine resolves critical illness-related colonic ileus in intensive care patients with multiple organ failure--a prospective, double-blind, placebo-controlled trial. Intensive Care Med 2001; 27: 822-827
  CrossrefPubMedGoogle Scholar
• 135 Rao SS, Yu S, Fedewa A. Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome. Aliment Pharmacol Ther 2015; 41: 1256-1270
  CrossrefPubMedGoogle Scholar
• 136 Klauser AG, Beck A, Schindlbeck NE. et al. Low fluid intake lowers stool output in healthy male volunteers. Z Gastroenterol 1990; 28: 606-609
  PubMedGoogle Scholar
• 137 Chien LY, Liou YM, Chang P. Low defaecation frequency in Taiwanese adolescents: association with dietary intake, physical activity and sedentary behaviour. J Paediatr Child Health 2011; 47: 381-386
  CrossrefPubMedGoogle Scholar
• 138 Anti M, Pignataro G, Armuzzi A. et al. Water supplementation enhances the effect of high-fiber diet on stool frequency and laxative consumption in adult patients with functional constipation. Hepatogastroenterology 1998; 45: 727-732
  PubMedGoogle Scholar
• 139 Chung BD, Parekh U, Sellin JH. Effect of increased fluid intake on stool output in normal healthy volunteers. J Clin Gastroenterol 1999; 28: 29-32
  CrossrefPubMedGoogle Scholar
• 140 Wood LN, Markowitz MA, Parameshwar PS. et al. Is it Safe to Reduce Water Intake in the Overactive Bladder Population? A Systematic Review. J Urol 2018; 200: 375-381
  CrossrefPubMedGoogle Scholar
• 141 Yang J, Wang HP, Zhou L. et al. Effect of dietary fiber on constipation: a meta analysis. World J Gastroenterol 2012; 18: 7378-7383
  CrossrefPubMedGoogle Scholar
• 142 Ford AC, Suares NC. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut 2011; 60: 209-218
  CrossrefPubMedGoogle Scholar
• 143 Dinning PG, Hunt L, Lubowski DZ. et al. The impact of laxative use upon symptoms in patients with proven slow transit constipation. BMC Gastroenterol 2011; 11: 121
  CrossrefPubMedGoogle Scholar
• 144 Emmanuel A, Cools M, Vandeplassche L. et al. Prucalopride improves bowel function and colonic transit time in patients with chronic constipation: an integrated analysis. Am J Gastroenterol 2014; 109: 887-894
  CrossrefPubMedGoogle Scholar
• 145 Shah ED, Kim HM, Schoenfeld P. Efficacy and Tolerability of Guanylate Cyclase-C Agonists for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis. Am J Gastroenterol 2018; 113: 329-338
  CrossrefPubMedGoogle Scholar
• 146 Quartero AO, Meineche-Schmidt V, Muris J. et al Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2005: CD003460
  PubMedGoogle Scholar
• 147 Ramkumar D, Rao SS. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol 2005; 100: 936-971
  CrossrefPubMedGoogle Scholar
• 148 Muller-Lissner SA, Kamm MA, Scarpignato C. et al. Myths and misconceptions about chronic constipation. Am J Gastroenterol 2005; 100: 232-242
  CrossrefPubMedGoogle Scholar
• 149 Bharucha AE, Low P, Camilleri M. et al. A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation. Gut 2013; 62: 708-715
  CrossrefPubMedGoogle Scholar
• 150 Bassotti G, Chiarioni G, Vantini I. et al. Effect of different doses of erythromycin on colonic motility in patients with slow transit constipation. Z Gastroenterol 1998; 36: 209-213
  PubMedGoogle Scholar
• 151 Dranove J, Horn D, Reddy SN. et al. Effect of intravenous erythromycin on the colonic motility of children and young adults during colonic manometry. J Pediatr Surg 2010; 45: 777-783
  CrossrefPubMedGoogle Scholar
• 152 Lacy BE, Schey R, Shiff SJ. et al. Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial. PLoS One 2015; 10: e0134349
  CrossrefPubMedGoogle Scholar
• 153 Schoenfeld P, Lacy BE, Chey WD. et al. Low-Dose Linaclotide (72 mug) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Am J Gastroenterol 2018; 113: 105-114
  CrossrefPubMedGoogle Scholar
• 154 Fukudo S, Miwa H, Nakajima A. et al. Dose-finding study of linaclotide in Japanese patients with chronic constipation: A phase II randomized, double-blind, and placebo-controlled study. Neurogastroenterol Motil 2018; 30: e13442
  CrossrefPubMedGoogle Scholar
• 155 Andresen V, Camilleri M, Busciglio IA. et al. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome. Gastroenterology 2007; 133: 761-768
  CrossrefPubMedGoogle Scholar
• 156 Fukudo S, Hongo M, Kaneko H. et al. Lubiprostone increases spontaneous bowel movement frequency and quality of life in patients with chronic idiopathic constipation. Clin Gastroenterol Hepatol 2015; 13: 294-301.e5
  CrossrefPubMedGoogle Scholar
• 157 Mollenbrink M, Bruckschen E. [Treatment of chronic constipation with physiologic Escherichia coli bacteria. Results of a clinical study of the effectiveness and tolerance of microbiological therapy with the E. coli Nissle 1917 strain (Mutaflor)]. Med Klin (Munich) 1994; 89: 587-593
  PubMedGoogle Scholar
• 158 Voderholzer WA, Schatke W, Muhldorfer BE. et al. Clinical response to dietary fiber treatment of chronic constipation. Am J Gastroenterol 1997; 92: 95-98
  PubMedGoogle Scholar
• 159 Yi Z, Jie C, Wenyi Z. et al. Comparison of efficacies of vegetable oil based and polyethylene glycol based bisacodyl suppositories in treating patients with neurogenic bowel dysfunction after spinal cord injury: a meta-analysis. Turk J Gastroenterol 2014; 25: 488-492
  CrossrefPubMedGoogle Scholar
• 160 Ruidisch MHH, H.J.; König, E. Laxanzien-Langzeittherapie mit Bisacodyl. Wirksamkeit und Verträglichkeit bei Patienten mit Rückenmarkverletzungen. Ärztliche Forschung 1994; 41: 3-8
  PubMedGoogle Scholar
• 161 Lazzaroni M, Casini V, Bianchi Porro G. Role or carbon dioxide-releasing suppositories in the treatment of chronic functional constipation: a double-blind, randomised, placebo-controlled trial. Clin Drug Investig 2005; 25: 499-505
  CrossrefPubMedGoogle Scholar
• 162 Chiarioni G, Heymen S, Whitehead WE. Biofeedback therapy for dyssynergic defecation. World J Gastroenterol 2006; 12: 7069-7074
  CrossrefPubMedGoogle Scholar
• 163 Heymen S, Scarlett Y, Jones K. et al. Randomized, controlled trial shows biofeedback to be superior to alternative treatments for patients with pelvic floor dyssynergia-type constipation. Dis Colon Rectum 2007; 50: 428-441
  CrossrefPubMedGoogle Scholar
• 164 Chiarioni G, Salandini L, Whitehead WE. Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. Gastroenterology 2005; 129: 86-97
  CrossrefPubMedGoogle Scholar
• 165 Koh CE, Young CJ, Young JM. et al. Systematic review of randomized controlled trials of the effectiveness of biofeedback for pelvic floor dysfunction. Br J Surg 2008; 95: 1079-1087
  CrossrefPubMedGoogle Scholar
• 166 Enck P, Van der Voort IR, Klosterhalfen S. Biofeedback therapy in fecal incontinence and constipation. Neurogastroenterol Motil 2009; 21: 1133-1141
  CrossrefPubMedGoogle Scholar
• 167 Woodward S, Norton C, Chiarelli P. Biofeedback for treatment of chronic idiopathic constipation in adults. Cochrane Database Syst Rev 2014: Cd008486
  PubMedGoogle Scholar
• 168 Rao SS, Benninga MA, Bharucha AE. et al. ANMS-ESNM position paper and consensus guidelines on biofeedback therapy for anorectal disorders. Neurogastroenterol Motil 2015; 27: 594-609
  CrossrefPubMedGoogle Scholar
• 169 Lee HJ, Jung KW, Myung SJ. Technique of functional and motility test: how to perform biofeedback for constipation and fecal incontinence. J Neurogastroenterol Motil 2013; 19: 532-537
  CrossrefPubMedGoogle Scholar
• 170 Emile SH, Elfeki HA, Elbanna HG. et al. Efficacy and safety of botulinum toxin in treatment of anismus: A systematic review. World J Gastrointest Pharmacol Ther 2016; 7: 453-462
  CrossrefPubMedGoogle Scholar
• 171 Han-Geurts IJ, Hendrix VC, de Blaauw I. et al. Outcome after anal intrasphincteric Botox injection in children with surgically treated Hirschsprung disease. J Pediatr Gastroenterol Nutr 2014; 59: 604-607
  CrossrefPubMedGoogle Scholar
• 172 Dinning PG, Hunt L, Patton V. et al. Treatment efficacy of sacral nerve stimulation in slow transit constipation: a two-phase, double-blind randomized controlled crossover study. Am J Gastroenterol 2015; 110: 733-740
  CrossrefPubMedGoogle Scholar
• 173 Kamm MA, Dudding TC, Melenhorst J. et al. Sacral nerve stimulation for intractable constipation. Gut 2010; 59: 333-340
  CrossrefPubMedGoogle Scholar
• 174 Carrington EV, Evers J, Grossi U. et al. A systematic review of sacral nerve stimulation mechanisms in the treatment of fecal incontinence and constipation. Neurogastroenterol Motil 2014; 26: 1222-1237
  CrossrefPubMedGoogle Scholar
• 175 Neuvonen MI, Kyrklund K, Rintala RJ. et al. Bowel Function and Quality of Life After Transanal Endorectal Pull-through for Hirschsprung Disease: Controlled Outcomes up to Adulthood. Annals of surgery 2017; 265: 622-629
  CrossrefPubMedGoogle Scholar
• 176 Coran AG, Teitelbaum DH. Recent advances in the management of Hirschsprungʼs disease. Am J Surg 2000; 180: 382-387
  CrossrefPubMedGoogle Scholar
• 177 Weidner BC, Waldhausen JH. Swenson revisited: a one-stage, transanal pull-through procedure for Hirschsprungʼs disease. J Pediatr Surg 2003; 38: 1208-1211
  CrossrefPubMedGoogle Scholar
• 178 Rintala RJ. Transanal coloanal pull-through with a short muscular cuff for classic Hirschsprung’s disease. Eur J Pediatr Surg 2003; 13: 181-186
  Article in Thieme ConnectPubMedGoogle Scholar
• 179 Hadidi A. Transanal endorectal pull-through for Hirschsprungʼs disease: a comparison with the open technique. Eur J Pediatr Surg 2003; 13: 176-180
  Article in Thieme ConnectPubMedGoogle Scholar
• 180 Langer JC, Durrant AC, de la Torre L. et al One-stage transanal Soave pullthrough for Hirschsprung disease: a multicenter experience with 141 children. Ann Surg 2003; 238: 569-583 ; discussion 583–585
  CrossrefPubMedGoogle Scholar
• 181 Tomita R, Ikeda T, Fujisaki S. et al. Hirschsprungʼs disease and its allied disorders in adults' histological and clinical studies. Hepatogastroenterology 2003; 50: 1050-1053
  PubMedGoogle Scholar
• 182 Saleh W, Rasheed K, Mohaidly MA. et al. Management of Hirschsprungʼs disease: a comparison of Soaveʼs and Duhamelʼs pull-through methods. Pediatr Surg Int 2004; 20: 590-593
  CrossrefPubMedGoogle Scholar
• 183 Chen Y, Nah SA, Laksmi NK. et al. Transanal endorectal pull-through versus transabdominal approach for Hirschsprung’s disease: a systematic review and meta-analysis. J Pediatr Surg 2013; 48: 642-651
  CrossrefPubMedGoogle Scholar
• 184 Hyman PE. Adolescents and young adults with Hirschsprungʼs disease. Curr Gastroenterol Rep 2006; 8: 425-429
  CrossrefPubMedGoogle Scholar
• 185 Miyamoto M, Egami K, Maeda S. et al. Hirschsprung’s disease in adults: report of a case and review of the literature. J Nippon Med Sch 2005; 72: 113-120
  CrossrefPubMedGoogle Scholar
• 186 Nyam DC, Pemberton JH, Ilstrup DM. et al. Long-term results of surgery for chronic constipation. Dis Colon Rectum 1997; 40: 273-279
  CrossrefPubMedGoogle Scholar
• 187 Kamm MA, Hawley PR, Lennard-Jones JE. Outcome of colectomy for severe idiopathic constipation. Gut 1988; 29: 969-973
  CrossrefPubMedGoogle Scholar
• 188 Ripetti V, Caputo D, Greco S. et al. Is total colectomy the right choice in intractable slow-transit constipation?. Surgery 2006; 140: 435-440
  CrossrefPubMedGoogle Scholar